- PRA052 is the second clinical candidate identified using the Prometheus360™ platform with one of the strongest genetic associations to IBD and is linked to a broad range of immune-mediated diseases ...
SEATTLE--(BUSINESS WIRE)--Today, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), announced the general availability of Amazon Managed Service for Prometheus, a scalable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results